GeneXpert or chest-X-ray or tuberculin skin testing for household contact assessment (GXT): protocol for a cluster-randomized trial

dc.contributor.authorTrajman, Anete
dc.contributor.authorAdjobimey, Menonli
dc.contributor.authorBastos, Mayara Lisboa
dc.contributor.authorValiquette, Chantal
dc.contributor.authorOxlade, Olivia
dc.contributor.authorFregonese, Federica
dc.contributor.authorAfolabi, Dissou
dc.contributor.authorCordeiro‐Santos, Marcelo
dc.contributor.authorStein, Renato T.
dc.contributor.authorBenedetti, Andrea
dc.contributor.authorMenzies, Dick
dc.date.accessioned2025-01-27T12:23:28Z
dc.date.available2025-01-27T12:23:28Z
dc.date.issued2022
dc.description.abstractBackground: The World Health Organization recommends tuberculosis (TB) preventive treatment (TPT) for all people living with HIV (PLH) and household contacts (HHC) of index TB patients. Tests for TB infection (TBI) or to rule out TB disease (TBD) are preferred, but if not available, this should not be a barrier if access to these tests is limited for high-risk people, such as PLH and HHC under 5 years old. There is equipoise on the need for these tests in diferent risk populations, especially HHC aged over 5. Methods: This superiority cluster-randomized multicenter trial with three arms of equal size compares, in Benin and Brazil, three strategies for HHC investigation aged 0–50: (i) tuberculin skin testing (TST) or interferon gamma release assay (IGRA) for TBI and if positive, chest X-Ray (CXR) to rule out TBD in persons with positive TST or IGRA; (ii) same as (i) but GeneXpert (GX) replaces CXR; and (iii) no TBI testing. CXR for all; if CXR is normal, TPT is recommended. All strategies start with symptom screening. Clusters are defned as HHC members of the same index patients with newly diagnosed pulmonary TBD. The main outcome is the proportion of HHC that are TPT eligible who start TPT within 3 months of the index TB patient starting TBD treatment. Societal costs, incidence of severe adverse events, and prevalence of TBD are among secondary outcomes. Stratifed analyses by age (under versus over 5) and by index patient microbiological status will be conducted. All participants provide signed informed consent. The study was approved by the Research Ethic Board of the Research Institute of the McGill University Health Centre, the Brazilian National Ethical Board CONEP, and the “Comité Local d’Éthique Pour la Recherche Biomédicale (CLERB) de l’Université de Parakou,” Benin. Findings will be submit‐ ted for publication in major medical journals and presented in conferences, to WHO and National and municipal TB programs of the involved countries. Discussion: This randomized trial is meant to provide high-quality evidence to inform WHO recommendations on investigation of household contacts, as currently these are based on very low-quality evidence Trial registration: ClinicalTrials.gov NCT04528823.
dc.identifier.citationTrajman A, Adjobimey M, Bastos ML, Valiquette C, Oxlade O, Fregonese F, Affolabi D, Cordeiro-Santos M, Stein RT, Benedetti A, Menzies D. GeneXpert or chest-X-ray or tuberculin skin testing for household contact assessment (GXT): protocol for a cluster-randomized trial. Trials. 2022 Aug 2;23(1):624. doi: 10.1186/s13063-022-06587-0.
dc.identifier.otherDOI: 10.1186/s13063-022-06587-0
dc.identifier.urihttps://dspace.inc.saude.gov.br/handle/123456789/750
dc.language.isoen
dc.publisherTrials Journal
dc.subjectLatent tuberculosisen
dc.subjectGeneXperten
dc.subjectChest X-rayen
dc.subjectTuberculin skin testingen
dc.subjectHousehold contactsen
dc.subjectCascade of care.en
dc.titleGeneXpert or chest-X-ray or tuberculin skin testing for household contact assessment (GXT): protocol for a cluster-randomized trial
dc.typeArticle
Arquivos
Original bundle
Agora exibindo 1 - 1 de 1
thumbnail.default.alt
Nome:
Trajman A et al_Trials.pdf
Tamanho:
197.55 KB
Formato:
Adobe Portable Document Format
Descrição:
License bundle
Agora exibindo 1 - 1 de 1
thumbnail.default.placeholder
Nome:
license.txt
Tamanho:
1.71 KB
Formato:
Item-specific license agreed to upon submission
Descrição: